TRENDING TOPICS
3055 articles found for "investing"
Axsome Therapeutics stock jumps to 52-week high after FDA accepts and grants priority review for AXS-05 to treat Alzheimer's disease agitation, with decision expected by April 2026.
Deckers Outdoor lost 53% in 2025 after tariff fears and slowing growth crushed the Hoka and UGG parent company. After nine years of gains, it's now the S&P 500's biggest loser.
Warner Bros. Discovery is at the center of a $108B bidding war between Netflix and Paramount-Skydance. The outcome could reshape the media industry for decades.
Google's parent company ends 2025 with a 66% surge, its best year since 2009, as Gemini AI breakthroughs propel shares toward the exclusive $4 trillion club.
Individual investors have poured $8 billion into Palantir in 2025, ignoring Wall Street's warnings about extreme valuations. Here's what's driving the phenomenon.
Nvidia closes 2025 with its largest acquisition ever, the $20 billion Groq deal, while pursuing AI21 Labs for $3 billion. The AI chip giant cements its market position.
Tesla takes unusual step of releasing lower delivery consensus ahead of Q4 report, signaling 2025 will mark second consecutive year of declining vehicle deliveries.
BioMarin Pharmaceutical will acquire Amicus Therapeutics for $4.8 billion in cash, creating a dominant force in lysosomal storage disorders.
Insilico Medicine raised HKD 2.277 billion in Hong Kong's largest biotech IPO of 2025, marking a milestone for AI-powered pharmaceutical development.
Starting January 1, 2026, China's new silver export restrictions will block smaller exporters and create a global supply shock. Here's what investors need to know.
Applied Digital announced plans to spin off its cloud business and merge it with Ekso Bionics to create ChronoScale, a new AI-focused computing platform.
Google's Gemini AI has tripled its market share from 5% to 18% in 2025, sending OpenAI into 'code red' mode as Alphabet emerges as the new AI leader.